DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Ginès P, Wong F, Milutinovic D. et al.
Effects of satavaptan (SR121463B), a selective vasopressin V2 receptor antagonist on serum sodium concentration and ascites in patients with cirrhosis hyponatremia
J Hepatol 2006; 44: 732A-
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.